Response to Newman et al. (March 2006): Factitious increase in thyrotropin in a neonate caused by a maternally transmitted interfering substance [11]

Clinical Chemistry

Volumn 52, Issue 8, 2006, Pages 1615-1616

  John, Rhys ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; THYROTROPIN; ZANAMIVIR;

ANALYTICAL ERROR; BIOASSAY; BLOOD SAMPLING; CONGENITAL HYPOTHYROIDISM; DIAGNOSTIC ACCURACY; FACTITIOUS DISEASE; FOLLOW UP; HUMAN; IMMUNORADIOMETRIC ASSAY; LETTER; MATERNAL SERUM; NEWBORN SCREENING; RADIOIMMUNOASSAY; THYROTROPIN BLOOD LEVEL;

FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; THYROTROPIN;

EID: 33746640870     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.070185     Document Type: Letter

References (15)

1. Newman JD, Bergman PB, Doery JCG, Balazs NDH. Factitious increase in thyroptopin in a neonate caused by a maternally transmitted interfering substance [Letter]. Clin Chem 2006; 52:541-2.
2. Lazarus JH, John R, Ginsburg J, Hughes IA, Shewring G, Smith BR, et al. Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone. BMJ 1983;286: 592-4.
3. Chaussain JL, Binet E, Job JC. Antibodies to human thyreotropin in the serum of certain hypopituitary dwarfs. Rev Eur Etudes Clin Biol 1972;17:95-9.
4. Biro J. Specific binding of thyroid-stimulating hormone by human serum globulins. J Endocrinol 1981;88:339-49.
5. Spitz IM, Le Roith D, Hirsch H, Carayon P, Pekonen F, Liel Y, et al. Increased high-molecular-weight thyrotropin with impaired biologic activity in a euthyroid man. N Engl J Med 1981;304:278-82.
6. Bifulco M, Spitz IM, Tedesco I, Vitale M, Aloj SM. The chemical nature of a high molecular weight human serum TSH [Abstract]. Ann Endocrinol (Paris) 1986;47:83.
7. Spira O, Gafni M, Ben-David C, Gross J, Gordon A. TSH binding proteins in rat and human serum. Acta Endocrinol (Copenh) 1987;115: 497-506.
8. Akamizu T, Mori T, Kasagi K, Kosugi S, Miyamoto M, Nishino K, et al. Anti-TSH Antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies. Clin Endocrinol 1987;26:311-20.
9. Akamizu T, Ishii H, Mori T, Ishihara T, Ikekubo K, Imura H, et al. Abnormal thyrotropin-binding immunoglobulins in two patients with Graves' disease. J Clin Endocrinol 1984;59:240-5.
10. Tamaki H, Takeoka K, Nishi I, Shindoh Y, Tsukada Y, Amino N. Novel thyrotropin (TSH)-TSH antibody complex in a healthy woman and her neonates. Thyroid 1995;5:299-303.
11. Halsall DJ, Barker P, Prentice A, Chatterjee VK, Fahie-Wilson MN. Macro FSH: elevated serum follicular stimulating hormone (FSH) due to an FSH-IgG complex. Clin Chim Acta 2005;355: S272.
12. Fahie-Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005;42:175-92.
13. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty year follow up of the Whickham Survey. Clin Endocrinol 1995;43:55-68.
14. Jospe N, Berkovitz GD, Corcoran LE, Humphrey RL. Factitious transient neonatal hyperthyrotropinemia. J Endocrinol Invest 1988;11:129-32.
15. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:1-126.